US Allergy Immunotherapies Market 2034: Sublingual Tablet Adoption...

added blog Other

2026-09-29 13:49:49 -

US Allergy Immunotherapies Market 2034: Sublingual Tablet Adoption and Home-Based Treatment Management

Sublingual allergen tablets are an important segment of the US Allergy Immunotherapies Market, particularly for selected pollen and house dust mite allergies. The FDA lists licensed products including GRASTEK, ORALAIR, RAGWITEK, and ODACTRA for specific allergic conditions. Their oral administration can support treatment models that differ from injection-based immunotherapy. Patient education,...

0 Comments 0 Shares 4 Views 0 Reviews